Polaris Venture Management Co. V, L.L.C., Ten Percent Owner at Genocea Biosciences, holds 7.27K shares in Lyra Therapeutics (Ticker: LYRA), holds 3.21M shares in Phreesia (Ticker: PHR), holds 21.33K shares in Cardlytics (Ticker: CDLX). Most recently, Polaris Venture Management Co. V, L.L.C. Bought ― shares of Lyra Therapeutics on May 06, 2020 for an estimated value of 1.00M.
What was Polaris Venture Management Co. V, L.L.C.’s latest transaction?
Polaris Venture Management Co. V, L.L.C. latest transaction was an Informative Buy of $1.00M.
What was Polaris Venture Management Co. V, L.L.C.'s most profitable transaction?
Polaris Venture Management Co. V, L.L.C.’s most profitable transaction was an Informative Sell of OCUL stock on February 4, 2015. The return on the trade was 79.60%.
What is Polaris Venture Management Co. V, L.L.C.'s role in Genocea Biosciences?
Polaris Venture Management Co. V, L.L.C.'s role in Genocea Biosciences is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.